Growth and growth factors in diabetes mellitus. 1987

S Salardi, and S Tonioli, and P Tassoni, and M Tellarini, and L Mazzanti, and E Cacciari

Growth of 79 children with diabetes was analysed at diagnosis and again after one to 10.7 years of treatment with insulin. Both sexes were tall at onset, whereas at the last observation boys alone showed significant growth retardation. Height standard deviation score (SDS), however, showed no significant fall either in 32 subjects reassessed after five years of disease or in 18 subjects examined at full stature. Skeletal maturity was not significantly impaired after treatment. Pubertal growth spurt was reduced, especially in girls and in subjects with onset of disease at or around puberty. We found no significant correlation between height and height velocity SDS and glycosylated haemoglobin values or secretion of growth hormone during the arginine test. Somatomedin C values were correlated with height velocity SDS in prepubertal boys. The results of this study suggest that there are interferences in the growth of children with diabetes but that they do not seem to have a significant influence on adult height.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D008297 Male Males
D001827 Body Height The distance from the sole to the crown of the head with body standing on a flat surface and fully extended. Body Heights,Height, Body,Heights, Body
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D005260 Female Females
D006128 Growth Gradual increase in the number, the size, and the complexity of cells of an individual. Growth generally results in increase in ORGAN WEIGHT; BODY WEIGHT; and BODY HEIGHT.
D006130 Growth Disorders Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth. Stunted Growth,Stunting,Disorder, Growth,Growth Disorder,Growth, Stunted,Stuntings

Related Publications

S Salardi, and S Tonioli, and P Tassoni, and M Tellarini, and L Mazzanti, and E Cacciari
January 1987, Journees annuelles de diabetologie de l'Hotel-Dieu,
S Salardi, and S Tonioli, and P Tassoni, and M Tellarini, and L Mazzanti, and E Cacciari
April 1998, Critical reviews in clinical laboratory sciences,
S Salardi, and S Tonioli, and P Tassoni, and M Tellarini, and L Mazzanti, and E Cacciari
May 1990, Seminars in nephrology,
S Salardi, and S Tonioli, and P Tassoni, and M Tellarini, and L Mazzanti, and E Cacciari
June 1995, Archives of disease in childhood,
S Salardi, and S Tonioli, and P Tassoni, and M Tellarini, and L Mazzanti, and E Cacciari
January 1955, Revista iberica de endocrinologia,
S Salardi, and S Tonioli, and P Tassoni, and M Tellarini, and L Mazzanti, and E Cacciari
October 1957, Deutsche medizinische Wochenschrift (1946),
S Salardi, and S Tonioli, and P Tassoni, and M Tellarini, and L Mazzanti, and E Cacciari
January 2016, Current neuropharmacology,
S Salardi, and S Tonioli, and P Tassoni, and M Tellarini, and L Mazzanti, and E Cacciari
August 1990, Rinsho byori. The Japanese journal of clinical pathology,
S Salardi, and S Tonioli, and P Tassoni, and M Tellarini, and L Mazzanti, and E Cacciari
July 1987, Diabete & metabolisme,
S Salardi, and S Tonioli, and P Tassoni, and M Tellarini, and L Mazzanti, and E Cacciari
January 1985, Hormone and metabolic research. Supplement series,
Copied contents to your clipboard!